These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10111726)
61. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections. Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294 [TBL] [Abstract][Full Text] [Related]
62. An aminoglycoside monitoring service in a community hospital using a microcomputer. Voytovich RM; Outten RL Hosp Pharm; 1987 Mar; 22(3):267-72. PubMed ID: 10281372 [TBL] [Abstract][Full Text] [Related]
63. Appropriate but not cost effective ceftazidime use in a university hospital. Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376 [TBL] [Abstract][Full Text] [Related]
64. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus. Morgan AS; Brennan PJ; Fishman NO Ann Pharmacother; 1997 Sep; 31(9):970-3. PubMed ID: 9296233 [TBL] [Abstract][Full Text] [Related]
65. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Borch JE; Andersen KE; Bindslev-Jensen C Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):357-62. PubMed ID: 16623858 [TBL] [Abstract][Full Text] [Related]
66. How pharmaceutical controls worked in one Ontario hospital. McLean WM; Tierney MG Can J Hosp Pharm; 1994 Aug; 47(4):176-9. PubMed ID: 10136951 [No Abstract] [Full Text] [Related]
67. Medication use and potential drug interactions in pediatric patients with infectious diseases. Lisby SM; Nahata MC Hosp Pharm; 1987 Apr; 22(4):354, 356. PubMed ID: 10281735 [TBL] [Abstract][Full Text] [Related]
68. A cost containment tool for antibiotics. Judd C; Moist L; Rose C; Gopaul D Dimens Health Serv; 1989 Nov; 66(8):25-6. PubMed ID: 2606294 [No Abstract] [Full Text] [Related]
69. The effect of an education program on cefazolin prescribing. Blain L; O'Brodovich M Can J Hosp Pharm; 1989 Apr; 42(2):69-71. PubMed ID: 10292923 [TBL] [Abstract][Full Text] [Related]
70. Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change. Schwartzberg E; Rubinovich S; Hassin D; Haspel J; Ben-Moshe A; Oren M; Shani S J Clin Pharm Ther; 2006 Apr; 31(2):179-85. PubMed ID: 16635053 [TBL] [Abstract][Full Text] [Related]
71. Cost containment through therapeutic substitution of aminoglycosides. Guernsey BG; Berina LF; Lazarus MC; Hokanson JA; Prohaska C; Allen JA; Doutre WH; Mader JT Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312 [TBL] [Abstract][Full Text] [Related]
72. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing. Khanderia U Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722 [TBL] [Abstract][Full Text] [Related]
77. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Soumerai SB; Avorn J Milbank Mem Fund Q Health Soc; 1984; 62(3):447-74. PubMed ID: 6433223 [No Abstract] [Full Text] [Related]
78. Pharmacy: computerless drug use review. Deliganis SG; Johnson SR Hospitals; 1973 Dec; 47(23):86 passim. PubMed ID: 4761628 [No Abstract] [Full Text] [Related]
79. Improving the appropriateness of vancomycin use by sequential interventions. Lipsky BA; Baker CA; McDonald LL; Suzuki NT Am J Infect Control; 1999 Apr; 27(2):84-91. PubMed ID: 10196484 [TBL] [Abstract][Full Text] [Related]
80. Consultant pharmacists to assist with cost-containment and enhanced drug use management. Payne L; Crone K; Pilla J Can J Hosp Pharm; 1990 Oct; 43(5):247-8. PubMed ID: 10107927 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]